Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the felgehiwot referral hospital, Ethiopia

被引：21

作者：

Abera B. ^{[1
]}

Zenebe Y. ^{[1
]}

Mulu W. ^{[1
]}

Kibret M. ^{[2
]}

Kahsu G. ^{[3
]}

机构：

[1] Department of Medical Microbiology, Parasitology and Immunology, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar

[2] Department of Biology, Science College, Bahir Dar University, Bahir Dar

[3] Bahir Dar Regional Health Research Laboratory Center, Bahir Dar

来源：

BMC Research Notes | / 7卷 / 1期

关键词：

ALT; Children; HBV; HCV; HIV;

D O I：

10.1186/1756-0500-7-838

中图分类号：

学科分类号：

摘要：

Background: Liver hepatitis due to Hepatitis B (HBV) and hepatitis C virus (HCV) co-infection is the leading cause of morbidity and mortality in HIV infected children and it is more severe in resource poor settings. Data on seroprevalence of HBV and HCV among HIV infected children are scarce in Ethiopia. This study was conducted to determine seroprevalence and risk factors of HBV and HCV and its effect on liver enzyme among HIV-positive children aged 18 months to 15 years attending the paediatric HIV care and treatment clinic at Felege Hiwot referral hospital, Ethiopia. Methods: A cross-sectional study was conducted in May, 2014. Demographic and risk factors were collected using a structured questionnaire. Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies were detected using an enzyme linked immunosorbent assay (ELISA). Alanine aminotransferase (ALT) levels were determined. The results were analyzed using descriptive and logistic regression. Results: A total of 253 HIV positive children, boys (52.5%) and girls (47.5%) took part in the study. The median age of the children was 11 years. Overall, 19 (7.5%) of HIV infected children were positive either for HBsAg or anti-HCV antibodies. The seroprevalence of HBV and HCV were 2.0% and 5.5%, respectively. All HBsAg positive children were in older age groups (11-15years). Seroprevalence of HCV was higher in children from urban (7.7%) than rural (1.2%) residents (P = 0.02). Overall, 29 (12.1%) of children had elevated ALT. Of these, 31.5% were from HBsAg or anti-HCV antibody positive children whereas 9.8% were from hepatitis B or C virus negative children (P = 0.001). Multivariate logistic regression showed that being positive for HBsAg or anti-HCV antibody (AOR: 4.7(95% CI: 1.5-13.5) was significantly associated with elevated ALT. Conclusion: HBV and HCV co-infections are common in HIV positive children. In HIV positive children, HBV and HCV co-infection were associated with elevate ALT. Routine screening for HBV and HCV in HIV infected children should be implemented. © 2014 Abera et al.

引用

共 32 条

[1]

Matthews C.P., Geretti A.M., GoulderP J.R., Klenerman P., Epidemiology of and impact of HIV coinfection with hepatitis B andHepatitis C viruses in Sub-Saharan Africa, J Clin Virol, 61, pp. 20-33, (2014)

[2]

Federal Ministry of Health (FMOH), Country Progress Report on HIV/AIDS Response, (2012)

[3]

Alter M.J., Epidemiology of viral hepatitis and HIV co-infection, J Hepatol, 44, pp. S6-S9, (2006)

[4]

Chu C.J., Lee S.D., Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment, J Gastroenterol Hepatol, 23, pp. 512-520, (2008)

[5]

Barth R.E., Huijgen Q., Taljaard J., Hoepelman A.I., Hepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis, Int J Infect Dis, 14, pp. e1024-e1031, (2010)

[6]

Dessie A., Abera B., Wale F., Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia, Ethiop J Health Dev, 21, pp. 68-69, (2007)

[7]

Gelaw B., Mengistu Y., Prevalence of HBV, HCV and malaria parasites among blood donors in Amhara and Tigray regional states, Ethiop J Health Dev, 22, pp. 3-7, (2007)

[8]

Gunn R.A., Murray P.J., Ackers M.L., Hardison W.G., Margolis H.S., Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic-rationale for integrating services, Sex Transm Dis, 28, pp. 166-170, (2001)

[9]

Andreoni M., Giacometti A., Maida I., Meraviglia P., Ripamonti D., Sarmati L., HIV-HCV co-infection: Epidemiology, pathogenesis and therapeutic implications, Eur Rev Med Pharmacol Sci, 16, pp. 1473-1483, (2012)

[10]

Tien P.C., Management and treatment of hepatitis C virus infection in HIV-infected adults: Recommendations from the veterans affairs hepatitis C resource cemter program and national hepatitis C program office, Am J Gastroenterol, 100, pp. 2338-2354, (2005)

← 1 2 3 4 →